Concepedia

HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies

Daniel Khalaf, Isabel M. Aragón, Matti Annala, Rosa M. Lozano, Sinja Taavitsainen, David Lorente, Daygen L. Finch, Nuria Romero-Laorden, Joanna Vergidis, Ylenia Cendón,

Annals of Oncology · 2020 · 43 citations · 23 references

DOIFull text

Open access

Concepts

References

23

A global reference for human genetic variation

Nature · 2015 · 19.2K citations · Full text

, , +6

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Charles J. Ryan, Matthew R. Smith, Johann S. de Bono et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Karim Fizazi, NamPhuong Tran, Luis Fein et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

Howard I. Scher, Michael J. Morris, Walter M. Stadler et al. · Journal of Clinical Oncology · 2016 · 1.5K citations · Full text

Androgen Levels Increase by Intratumoral <i>De novo</i> Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

Jennifer A. Locke, Emma S. Tomlinson Guns, Amy A. Lubik et al. · Cancer Research · 2008 · 735 citations · Full text

, , +15